Papillary Thyroid Carcinoma Managed at the Mayo Clinic during Six Decades (1940–1999): Temporal Trends in Initial Therapy and Long-term Outcome in 2444 Consecutively Treated Patients

By I. Hay, G. Thompson, C. Grant, E. Bergstralh, Catherine E. Dvorak, C. Gorman, Megan S. Maurer, B. Mciver, B. Mullan, A. Oberg and 3 more. World Journal of Surgery, 2002

726 citations recorded by the source corpus.

Subfields: Endocrinology, Diabetes and Metabolism, Radiology, Nuclear Medicine and Imaging, Surgery

View Paper: https://www.semanticscholar.org/paper/0a9a1fcf036b898bdb36783453eb8d6ab0b3c8a6

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Endocrinology, Diabetes and Metabolism

1. D. Cooper
2. Y. Nikiforov

In Radiology, Nuclear Medicine and Imaging

1. Christopher Sander

In Surgery

1. Y. Nikiforov
2. Eric S. Lander

Citations in the corpus

• Outcomes of Patients with Differentiated Thyroid Carcinoma Following Initial Therapy (2006, neutral): “The analysis of DFS may also be confounded by the use of RAI, which also enhances subsequent disease detection by thyroglobulin determination and RAI scanning, thus potentially leading to lead-time bias in the early identification of recurrence (26).”
• 2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer: The American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid Cancer (2009, positive): “Because disease staging and risk stratification should be used to guide initial prognostication, disease management, and follow-up strategies, accurate postoperative risk assessment is a crucial element in the management of patients with DTC (277,278).”
• Management Guidelines for Patients with Thyroid Nodules and Differentiated Thyroid Cancer: The American Thyroid Association Guidelines Taskforce (2006, neutral): “Older age ( (cid:2) 45 years) may also be a criterion for recommending near-total or total thyroidectomy because of higher recurrence rates in this age group (62,68,69,95,96).”
• Papillary microcarcinoma of the thyroid—Prognostic significance of lymph node metastasis and multifocality (2003, result): “Despite the documented effectiveness of RAI for the treatment of patients with differentiated thyroid carcinoma, such as reductions in recurrence rates, the regression of DM,(40) – 43 and improvements in survival,(25,32,35,36,44) a recently published study of 2444 patients from a single institute re”
• Guidelines for radioiodine therapy of differentiated thyroid cancer (2008, background): “When thyroid surgery is performed in highly expert hands at selected tertiary referral centres, though, the positive influence of radioiodine ablation may not be apparent [24].”
• Integrated Genomic Characterization of Papillary Thyroid Carcinoma (2014, background): “PTCs are usually curable with 5-year survival of over 95% (Hay et al., 2002); however, occasionally they dedifferentiate into more aggressive and lethal thyroid cancers.”
• Strategies of radioiodine ablation in patients with low-risk thyroid cancer. (2012, neutral): “Follicular 14 (7) 20 (11) 13 (7) 11 (6)”
• Revised American Thyroid Association Management Guidelines for Patients with Thyroid Nodules and Differentiated Thyroid Cancer (2009, positive): “In 1996, the American Thyroid Association (ATA) published treatment guidelines for patients with thyroid nodules and DTC (10).”